Legislation

How Will Canada's Bill C-72 Revolutionize Health IT Interoperability?
Digital Health How Will Canada's Bill C-72 Revolutionize Health IT Interoperability?

The Canadian healthcare system is on the brink of a significant transformation with the introduction of Bill C-72, also known as the Connected Care for Canadians Act. This groundbreaking legislation aims to create a cohesive and interoperable health information technology (IT) system across the

Virginia Launches Comprehensive Effort to Tackle PFAS Contamination
Regulatory & Compliance Virginia Launches Comprehensive Effort to Tackle PFAS Contamination

Virginia has recently embarked on a comprehensive process to identify the sources of per- and polyfluoroalkyl substances (PFAS), a group of chemicals often referred to as "forever chemicals" due to their persistent nature in the environment. This monumental initiative follows the adoption

Emulating Health Tech: Strategies for Accelerating Climate Tech Growth
Regulatory & Compliance Emulating Health Tech: Strategies for Accelerating Climate Tech Growth

The emerging field of climate technology (climate tech) has encountered numerous obstacles, including inconsistent public support and cautious investment behavior from venture capitalists. Despite the commendable efforts of grassroots organizations and climate innovators, large-scale and lasting

How Is the NHS Helping Residents Navigate Winter Healthcare Choices?
Regulatory & Compliance How Is the NHS Helping Residents Navigate Winter Healthcare Choices?

Each winter, healthcare systems face a surge in demand that often overwhelms their services. To tackle this perennial challenge, the NHS has launched an initiative to educate the public about available healthcare options during this busy season. NHS staff will be attending various events in Bedford

How Will New EU Health Tech Rules Impact Medical Device Supply?
Regulatory & Compliance How Will New EU Health Tech Rules Impact Medical Device Supply?

The European Union has recently rolled out significant amendments to its Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) with the goal of addressing potential supply chain disruptions that could jeopardize the availability of medical devices and diagnostics. These

Are PBMs and Pharma Companies Driving High Insulin Prices?
Regulatory & Compliance Are PBMs and Pharma Companies Driving High Insulin Prices?

The rise in insulin prices has become a heated topic in healthcare discussions, drawing scrutiny towards the roles played by pharmacy benefit managers (PBMs) and pharmaceutical companies. Recently, Texas Attorney General Ken Paxton has taken a significant legal step by suing major PBMs and pharma

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later